Skip to NavigationSkip to content

News

0
A key player throughout 2016, the pharmaceutical market in China is one of the most promising for US exports in the long-term given its size and...
0
The study, conducted by researchers at MIT, involved LED lights flickering at specific frequencies to determine whether this reduced the beta amyloid...
0
Venclyxto (venetoclax) has been granted marketing authorisation by the European Commission (EC) as a monotherapy for the treatment of chronic...
0
Novartis have released that its drug, Zykadia, in Phase III trials, was twice as effective at slowing progression in advanced non-small cell lung...

Features

Spend any time looking into patient adherence and some remarkable figures will come your way: huge losses of money, major pressure placed on...